1. Short title This Act may be cited as the Crowdfunding to Combat the Coronavirus Act . 2. Expansion of certain securities exemptions to respond to COVID–19 (a) Definitions Section 2(a) of the Securities Act of 1933 ( 15 U.S.C. 77b(a) ) is amended by adding at the end the following: (20) Issuer combating COVID–19 The term issuer combating COVID–19 means an issuer that undertakes— (A) efforts to find a vaccine for COVID–19; (B) research or production of medical equipment related to COVID–19, including— (i) testing equipment; and (ii) touchless automation and hands-free proximity sensing technology; (C) research or production of technology or equipment related to social distancing or other non-medical strategies to reduce the danger of COVID–19 to the general population, including— (i) online education technology; and (ii) remote video conferencing technology; and (D) such other activities as the Commission may determine appropriate. . (b) Issue exemptive authority with respect to COVID–19 Section 3(b) of the Securities Act of 1933 ( 15 U.S.C. 77c(b) ) is amended— (1) in paragraph (1), by inserting after no issue of securities the following: (other than an issue of securities by an issuer combating COVID–19)